Thomas Tu is a venture capital investor at Vensana Capital who uniquely combines experience as a practicing interventional cardiologist, former Chief Medical Officer at Inari Medical, and key physician-innovator behind Inari's core thrombectomy technology that helped establish mechanical thrombectomy as a new standard of care for venous thromboembolism. As CEO of Vensana Innovation while serving as a Venture Partner, he not only picks companies but helps originate and build them from the ground up, leveraging his clinical trial, regulatory, and launch experience to shape how new medical device platforms are conceived and brought to market.